Vanguard Group Reveals Position in Spire Healthcare Group

The Vanguard Group, Inc. has issued a Form 8.3 disclosure, detailing its significant interest in Spire Healthcare Group plc. As of January 14, 2026, Vanguard holds 14,439,400 ordinary shares, representing a 3.59% stake in the company. This disclosure falls under Rule 8.3 of the Takeover Code, which necessitates the public declaration of positions held in relevant securities representing 1% or more.

Recent transactions include the purchase of 1,776 ordinary shares at 1.80 GBP each and the sale of 475 shares at 1.79 GBP each. No cash-settled or stock-settled derivatives were reported. Furthermore, no agreements, arrangements, or understandings concerning options or derivatives were declared.

Vanguard’s disclosure highlights its notable interest in Spire Healthcare, without any additional connected disclosures.